Christopher S. Nabel
Impact in
- Oncology top 5%
- Viral-associated cancers and disorders
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- DNA Repair Mechanisms
Papers in
-
- Epigenetics and DNA Methylation 8
- RNA modifications and cancer 4
- DNA Repair Mechanisms 2
- Oncology 8
- Viral-associated cancers and disorders 4
- Co-authors
- Rahul M. Kohli (7 shared papers)Frits van Rhee (4 shared papers)David C. Fajgenbaum (4 shared papers)James T. Stivers (1 shared paper)Hana L. Goldschmidt (1 shared paper)Huijue Jia (1 shared paper)Li Shen (1 shared paper)Yi Zhang (1 shared paper)
- Journals
- Molecular Cell (2 papers)Cancer Research (2 papers)The Oncologist (2 papers)Genome biology (1 paper)Translational Lung Cancer Research (1 paper)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
Christopher S. Nabel
25 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 120
- Oncology 490
- Molecular Biology 1.1k
- Virology 61
- Rheumatology 180
- Infectious Diseases 226
Countries citing papers authored by Christopher S. Nabel
This map shows the geographic impact of Christopher S. Nabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Nabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Nabel more than expected).
Fields of papers citing papers by Christopher S. Nabel
This network shows the impact of papers produced by Christopher S. Nabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Nabel. The network helps show where Christopher S. Nabel may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher S. Nabel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 251 | |
| 2 | 2014 | 227 | |
| 3 | 2016 | 199 | |
| 4 | 2013 | 189 | |
| 5 | 2018 | 156 | |
| 6 | 2011 | 140 | |
| 7 | 2012 | 124 | |
| 8 | 2011 | 109 | |
| 9 | 2019 | 104 | |
| 10 | 2022 | 101 | |
| 11 | 2017 | 71 | |
| 12 | 2018 | 60 | |
| 13 | 2016 | 55 | |
| 14 | 2019 | 28 | |
| 15 | 2013 | 28 | |
| 16 | 2024 | 26 | |
| 17 | 2025 | 12 | |
| 18 | 2019 | 11 | |
| 19 | 2024 | 9 | |
| 20 | 2024 | 3 |
About Christopher S. Nabel
Christopher S. Nabel is a scholar working on Molecular Biology, Oncology, Epidemiology, Infectious Diseases and Virology, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Viral-associated cancers and disorders (4 papers), Cytomegalovirus and herpesvirus research (4 papers), RNA modifications and cancer (4 papers), HIV Research and Treatment (3 papers), DNA Repair Mechanisms (2 papers), Adenosine and Purinergic Signaling (2 papers) and Histiocytic Disorders and Treatments (2 papers). The work is most often cited by research in Oncology (490 citations), Molecular Biology (1.1k citations), Virology (61 citations), Rheumatology (180 citations) and Infectious Diseases (226 citations). Christopher S. Nabel has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Rahul M. Kohli, Frits van Rhee, David C. Fajgenbaum, James T. Stivers, Hana L. Goldschmidt, Huijue Jia, Li Shen, Yi Zhang, Yu Ye and Emily K. Schutsky. Their work appears in journals such as Molecular Cell, Cancer Research, The Oncologist, Genome biology and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.